Table 1.

Predicted CTL epitopes with MHC I binding epitopes against human emerging pathogenic SARS-CoV, MERS-CoV, and SARS-CoV-2.

Selected Antigen	Organism	Position	CTL epitope	MHC-I epitope	Allele	Percentile rank
nsp3	SARS-CoV-2	829-840	LNHTKKWKY	MSALNHTKKWKY	HLA-B*57:01	0.26
	SARS-CoV	1184-1195	FEVLAVEDT	FEVLAVEDTQGM	HLA-A*26:01	0.62
	MERS-CoV	391-402	SFDYLIREA	AVSFDYLIREAK	HLA-A*11:01	0.32
nsp8	SARS-CoV-2	12-23	YAAFATAQE	YAAFATAQEAYE	HLA-B*35:01	0.21
	SARS-CoV	35-46	KKLKKSLNV	LKKLKKSLNVAK	HLA-A*03:01	2.10
	MERS-CoV	39-50	AVNIAKNAY	LQKAVNIAKNAY	HLA-B*15:01	0.52
S protein	SARS-CoV-2	27-38	YTNSFTRGV	AYTNSFTRGVYY	HLA-A*01:01	0.04
	SARS-CoV	454-465	ISNVPFSPD	DISNVPFSPDGK	HLA-A*11:01	1.40
	MERS-CoV	303-314	IQSDRKAWA	IQSDRKAWAAFY	HLA-A*01:01	0.11
M protein	SARS-CoV-2	185-196	RVAGDSGFA	QRVAGDSGFAAY	HLA-A*30:02	0.06
	SARS-CoV	53-64	LWLLWPVTL	LWLLWPVTLACF	HLA-A*23:01	0.32
	MERS-CoV	152-163	HFGACDYDR	GMHFGACDYDRL	HLA-B*38:01	0.49
N protein	SARS-CoV-2	45-56	NNTASWFTA	LPNNTASWFTAL	HLA-B*07:02	0.40
	SARS-CoV	62-73	EELRFPRGQ	KEELRFPRGQGV	HLA-C*07:01	1.40
	MERS-CoV	249-260	HKRTSTKSF	KMRHKRTSTKSF	HLA-A*03:01	0.80
Eprotein	SARS-CoV-2	33-44	TALRLCAYC	ILTALRLCAYCC	HLA-A*25:01	1.40
	SARS-CoV	50-61	VKPTVYVYS	SLVKPTVYVYSR	HLA-A*31:01	0.87
	MERS-CoV	49-60	VQPALYLYN	TLLVQPALYLYN	HLA-A*29:02	1.30